Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Novocal-Gold SG is a multi-ingredient nutraceutical softgel capsule developed by Captab Biotec. It is formulated to support bone health and treat nutritional deficiencies, particularly within the orthopedic range. The combination contains coral calcium (a highly bioavailable source of calcium and trace minerals) and calcitriol (the active form of vitamin D3) to enhance calcium absorption and maintain bone mineral density. It also includes methylcobalamin (vitamin B12) and pyridoxine (vitamin B6) to support nerve health and reduce homocysteine levels, folic acid to aid in red blood cell production, and zinc to support bone mineralization and immune function. Novocal-Gold SG is approved and marketed in India for conditions such as osteoporosis, hypocalcemia, and general bone loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on novocal-gold sg.